IPSEN (IPN.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:IPN - FR0010259150 - Common Stock
127.4 EUR
+0.7 (+0.55%)
We assign a fundamental rating of 6 out of 10 to IPN. IPN was compared to 55 industry peers in the Pharmaceuticals industry. While IPN has a great health rating, its profitability is only average at the moment. IPN has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year IPN was profitable.
IPN had a positive operating cash flow in the past year.
In the past 5 years IPN has always been profitable.
Each year in the past 5 years IPN had a positive operating cash flow.
1.2 Ratios
IPN has a Return On Assets of 6.56%. This is comparable to the rest of the industry: IPN outperforms 56.36% of its industry peers.
IPN's Return On Equity of 10.59% is in line compared to the rest of the industry. IPN outperforms 54.55% of its industry peers.
Looking at the Return On Invested Capital, with a value of 14.88%, IPN is in the better half of the industry, outperforming 78.18% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for IPN is in line with the industry average of 13.65%.
The last Return On Invested Capital (14.88%) for IPN is above the 3 year average (12.97%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.56% | ||
| ROE | 10.59% | ||
| ROIC | 14.88% |
ROA(3y)9.04%
ROA(5y)10.56%
ROE(3y)14.84%
ROE(5y)18.77%
ROIC(3y)12.97%
ROIC(5y)15.34%
1.3 Margins
The Profit Margin of IPN (11.91%) is comparable to the rest of the industry.
IPN's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 26.01%, IPN is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
In the last couple of years the Operating Margin of IPN has declined.
IPN has a Gross Margin of 83.32%. This is amongst the best in the industry. IPN outperforms 89.09% of its industry peers.
IPN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.01% | ||
| PM (TTM) | 11.91% | ||
| GM | 83.32% |
OM growth 3Y-13.94%
OM growth 5Y-4.28%
PM growth 3Y-25.63%
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so IPN is creating value.
IPN has more shares outstanding than it did 1 year ago.
IPN has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, IPN has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 4.58 indicates that IPN is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 4.58, IPN is doing good in the industry, outperforming 61.82% of the companies in the same industry.
The Debt to FCF ratio of IPN is 1.69, which is an excellent value as it means it would take IPN, only 1.69 years of fcf income to pay off all of its debts.
IPN's Debt to FCF ratio of 1.69 is amongst the best of the industry. IPN outperforms 89.09% of its industry peers.
IPN has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
IPN has a Debt to Equity ratio of 0.20. This is in the better half of the industry: IPN outperforms 78.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 1.69 | ||
| Altman-Z | 4.58 |
ROIC/WACC1.91
WACC7.81%
2.3 Liquidity
IPN has a Current Ratio of 1.98. This is a normal value and indicates that IPN is financially healthy and should not expect problems in meeting its short term obligations.
IPN has a Current ratio of 1.98. This is in the better half of the industry: IPN outperforms 72.73% of its industry peers.
IPN has a Quick Ratio of 1.80. This is a normal value and indicates that IPN is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.80, IPN belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.8 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 12.24% over the past year.
Measured over the past years, IPN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.79% on average per year.
IPN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.45%.
Measured over the past years, IPN shows a small growth in Revenue. The Revenue has been growing by 5.83% on average per year.
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%44.4%
Revenue 1Y (TTM)9.45%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%9.67%
3.2 Future
IPN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.58% yearly.
Based on estimates for the next years, IPN will show a small growth in Revenue. The Revenue will grow by 4.58% on average per year.
EPS Next Y10.08%
EPS Next 2Y3.94%
EPS Next 3Y4.55%
EPS Next 5Y5.58%
Revenue Next Year8.8%
Revenue Next 2Y6.24%
Revenue Next 3Y6.01%
Revenue Next 5Y4.58%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 12.41 indicates a correct valuation of IPN.
Based on the Price/Earnings ratio, IPN is valued a bit cheaper than 78.18% of the companies in the same industry.
IPN is valuated cheaply when we compare the Price/Earnings ratio to 27.19, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 11.48, which indicates a very decent valuation of IPN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IPN indicates a somewhat cheap valuation: IPN is cheaper than 76.36% of the companies listed in the same industry.
IPN is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.88, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.41 | ||
| Fwd PE | 11.48 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IPN indicates a rather cheap valuation: IPN is cheaper than 96.36% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, IPN is valued a bit cheaper than 63.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.7 | ||
| EV/EBITDA | 5.99 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
IPN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.23
PEG (5Y)1.41
EPS Next 2Y3.94%
EPS Next 3Y4.55%
5. Dividend
5.1 Amount
IPN has a Yearly Dividend Yield of 1.18%. Purely for dividend investing, there may be better candidates out there.
IPN's Dividend Yield is comparable with the industry average which is at 1.60.
Compared to the average S&P500 Dividend Yield of 1.94, IPN is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.18% |
5.2 History
The dividend of IPN has a limited annual growth rate of 3.72%.
Dividend Growth(5Y)3.72%
Div Incr Years1
Div Non Decr Years4
5.3 Sustainability
25.90% of the earnings are spent on dividend by IPN. This is a low number and sustainable payout ratio.
The dividend of IPN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP25.9%
EPS Next 2Y3.94%
EPS Next 3Y4.55%
EPA:IPN (1/9/2026, 7:00:00 PM)
127.4
+0.7 (+0.55%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners15.35%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap10.68B
Revenue(TTM)3.76B
Net Income(TTM)447.90M
Analysts68.89
Price Target131.89 (3.52%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.18% |
Yearly Dividend1.2
Dividend Growth(5Y)3.72%
DP25.9%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.59%
PT rev (3m)1.39%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.65%
EPS NY rev (3m)4.65%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.18%
Revenue NY rev (3m)1.62%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.41 | ||
| Fwd PE | 11.48 | ||
| P/S | 2.84 | ||
| P/FCF | 20.7 | ||
| P/OCF | 11.9 | ||
| P/B | 2.52 | ||
| P/tB | 8 | ||
| EV/EBITDA | 5.99 |
EPS(TTM)10.27
EY8.06%
EPS(NY)11.1
Fwd EY8.71%
FCF(TTM)6.15
FCFY4.83%
OCF(TTM)10.71
OCFY8.4%
SpS44.86
BVpS50.46
TBVpS15.93
PEG (NY)1.23
PEG (5Y)1.41
Graham Number107.98
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.56% | ||
| ROE | 10.59% | ||
| ROCE | 18.07% | ||
| ROIC | 14.88% | ||
| ROICexc | 20.46% | ||
| ROICexgc | 77.25% | ||
| OM | 26.01% | ||
| PM (TTM) | 11.91% | ||
| GM | 83.32% | ||
| FCFM | 13.72% |
ROA(3y)9.04%
ROA(5y)10.56%
ROE(3y)14.84%
ROE(5y)18.77%
ROIC(3y)12.97%
ROIC(5y)15.34%
ROICexc(3y)20.33%
ROICexc(5y)25.52%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)15.75%
ROCE(5y)18.64%
ROICexgc growth 3Y-59.92%
ROICexgc growth 5Y-22.83%
ROICexc growth 3Y-29.05%
ROICexc growth 5Y-11.89%
OM growth 3Y-13.94%
OM growth 5Y-4.28%
PM growth 3Y-25.63%
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
F-Score7
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 1.69 | ||
| Debt/EBITDA | 0.5 | ||
| Cap/Depr | 55.54% | ||
| Cap/Sales | 10.15% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 53.9% | ||
| Profit Quality | 115.14% | ||
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.8 | ||
| Altman-Z | 4.58 |
F-Score7
WACC7.81%
ROIC/WACC1.91
Cap/Depr(3y)131.36%
Cap/Depr(5y)124.73%
Cap/Sales(3y)11.81%
Cap/Sales(5y)11.18%
Profit Quality(3y)85.87%
Profit Quality(5y)89.99%
High Growth Momentum
Growth
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%44.4%
EPS Next Y10.08%
EPS Next 2Y3.94%
EPS Next 3Y4.55%
EPS Next 5Y5.58%
Revenue 1Y (TTM)9.45%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%9.67%
Revenue Next Year8.8%
Revenue Next 2Y6.24%
Revenue Next 3Y6.01%
Revenue Next 5Y4.58%
EBIT growth 1Y66.72%
EBIT growth 3Y-6.06%
EBIT growth 5Y1.3%
EBIT Next Year41.46%
EBIT Next 3Y13.73%
EBIT Next 5Y7.89%
FCF growth 1Y-33.64%
FCF growth 3Y-35.67%
FCF growth 5Y-17.46%
OCF growth 1Y-8.92%
OCF growth 3Y-0.07%
OCF growth 5Y7.84%
IPSEN / IPN.PA FAQ
What is the fundamental rating for IPN stock?
ChartMill assigns a fundamental rating of 6 / 10 to IPN.PA.
What is the valuation status of IPSEN (IPN.PA) stock?
ChartMill assigns a valuation rating of 6 / 10 to IPSEN (IPN.PA). This can be considered as Fairly Valued.
Can you provide the profitability details for IPSEN?
IPSEN (IPN.PA) has a profitability rating of 6 / 10.
What is the financial health of IPSEN (IPN.PA) stock?
The financial health rating of IPSEN (IPN.PA) is 7 / 10.
How sustainable is the dividend of IPSEN (IPN.PA) stock?
The dividend rating of IPSEN (IPN.PA) is 4 / 10 and the dividend payout ratio is 25.9%.